Molecular Biology of the Cell Call for Nominations: MBC Editor-in-Chief

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Vol. 15, Issue 5, 2302-2311, May 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yi, Y.
Right arrow Articles by Said, T. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yi, Y.
Right arrow Articles by Said, T. K.

p19ARF Determines the Balance between Normal Cell Proliferation Rate and Apoptosis during Mammary Gland Development

Yijun Yi, Anne Shepard, Frances Kittrell, Biserka Mulac-Jericevic, Daniel Medina, and Thenaa K. Said *

Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030

Submitted November 4, 2003; Revised January 30, 2004; Accepted February 27, 2004
Monitoring Editor: Keith Yamamoto

This study demonstrated, for the first time, the following events related to p19ARF involvement in mammary gland development: 1) Progesterone appears to regulate p19ARF in normal mammary gland during pregnancy. 2) p19ARF expression levels increased sixfold during pregnancy, and the protein level plateaus during lactation. 3) During involution, p19ARF protein level remained at high levels at 2 and 8 days of involution and then, declined sharply at day 15. Absence of p19ARF in mammary epithelial cells leads to two major changes, 1) a delay in the early phase of involution concomitant with downregulation of p21Cip1 and decrease in apoptosis, and 2) p19ARF null cells are immortal in vivo measured by serial transplantion, which is partly attributed to complete absence of p21Cip1 compared with WT cells. Although, p19ARF is dispensable in mammary alveologenesis, as evidenced by normal differentiation in the mammary gland of pregnant p19ARF null mice, the upregulation of p19ARF by progesterone in the WT cells and the weakness of p21Cip1 in mammary epithelial cells lacking p19ARF strongly suggest that the functional role(s) of p19ARF in mammary gland development is critical to sustain normal cell proliferation rate during pregnancy and normal apoptosis in involution possibly through the p53-dependent pathway.


Article published online ahead of print. Mol. Biol. Cell 10.1091/mbc.E03–11–0785. Article and publication date are available at www.molbiolcell.org/cgi/doi/10.1091/mbc.E03–11–0785.

* Corresponding author. E-mail address: tsaid{at}bcm.tmc.edu.




This article has been cited by other articles:


Home page
J Mol EndocrinolHome page
J J Brosens and B Gellersen
Death or survival - progesterone-dependent cell fate decisions in the human endometrial stroma.
J. Mol. Endocrinol., June 1, 2006; 36(3): 389 - 398.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2004 by The American Society for Cell Biology. Terms of copyright protection, warranties, and disclaimers.